March 9, 2023 02:06 PM ESTUpdated 02:27 PM
Pharma
FDA+

FDA makes rare 'mis­in­for­ma­tion' com­ment on Lu­ci­ra's EUA for its at-home Covid-19 and flu test

Katherine Lewin

News Reporter

The FDA has re­leased a rare com­ment on what hap­pened dur­ing Lu­ci­ra Health’s EUA fil­ing for the first at-home Covid-19 and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Key GOP sen­a­tor is ‘strug­gling’ with Kennedy nom­i­na­tion over vac­cine an­swers

Black­stone se­cures $1.6B so far for new life sci­ences fund tar­get­ed at $5B+

Roche aims for de­risked deals and ruth­less port­fo­lio cuts in 2025

Take­da scraps pro­grams as it rais­es full-year guid­ance 

FDA ap­proves Ax­some's acute mi­graine treat­ment af­ter 2022 re­jec­tion

sponsored

Why the pre­mier re­cruit­ment agency in the world is giv­ing up re­cruit­ing, and spon­sors should, too

A service from the Financial Times